• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多变量分析溶解度参数评估盐酸雷洛昔芬制备无定形固体分散体中药物-聚合物的相容性。

Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions.

机构信息

Laboratory of Nanosystems and Drug Delivery Devices (NanoSYS), School of Pharmacy, Universidade Federal de Goiás, Goiânia, Goiás, 74.605-170, Brazil.

Institute of Chemistry, Universidade Federal de Goiás, Goiânia, 74.001-970, Brazil.

出版信息

AAPS PharmSciTech. 2024 Jun 6;25(5):127. doi: 10.1208/s12249-024-02844-4.

DOI:10.1208/s12249-024-02844-4
PMID:38844724
Abstract

The success of obtaining solid dispersions for solubility improvement invariably depends on the miscibility of the drug and polymeric carriers. This study aimed to categorize and select polymeric carriers via the classical group contribution method using the multivariate analysis of the calculated solubility parameter of RX-HCl. The total, partial, and derivate parameters for RX-HCl were calculated. The data were compared with the results of excipients (N = 36), and a hierarchical clustering analysis was further performed. Solid dispersions of selected polymers in different drug loads were produced using solvent casting and characterized via X-ray diffraction, infrared spectroscopy and scanning electron microscopy. RX-HCl presented a Hansen solubility parameter (HSP) of 23.52 MPa. The exploratory analysis of HSP and relative energy difference (RED) elicited a classification for miscible (n = 11), partially miscible (n = 15), and immiscible (n = 10) combinations. The experimental validation followed by a principal component regression exhibited a significant correlation between the crystallinity reduction and calculated parameters, whereas the spectroscopic evaluation highlighted the hydrogen-bonding contribution towards amorphization. The systematic approach presented a high discrimination ability, contributing to optimal excipient selection for the obtention of solid solutions of RX-HCl.

摘要

获得改善溶解度的固体分散体的成功通常取决于药物和聚合物载体的混溶性。本研究旨在通过多元分析 RX-HCl 的计算溶解度参数,使用经典的基团贡献法对聚合物载体进行分类和选择。计算了 RX-HCl 的总、部分和导数参数。将数据与赋形剂的结果(N=36)进行了比较,并进一步进行了层次聚类分析。使用溶剂浇铸法制备了选定聚合物在不同药物载量下的固体分散体,并通过 X 射线衍射、红外光谱和扫描电子显微镜对其进行了表征。RX-HCl 的汉森溶解度参数(HSP)为 23.52 MPa。对 HSP 和相对能量差(RED)的探索性分析得出了可混溶(n=11)、部分可混溶(n=15)和不可混溶(n=10)组合的分类。实验验证后进行主成分回归,表明结晶度降低与计算参数之间存在显著相关性,而光谱评估则突出了氢键对非晶化的贡献。该系统方法具有较高的鉴别能力,有助于为获得 RX-HCl 的固体溶液选择最佳赋形剂。

相似文献

1
Multivariate Analysis of Solubility Parameters for Drug-Polymer Miscibility Assessment in Preparing Raloxifene Hydrochloride Amorphous Solid Dispersions.多变量分析溶解度参数评估盐酸雷洛昔芬制备无定形固体分散体中药物-聚合物的相容性。
AAPS PharmSciTech. 2024 Jun 6;25(5):127. doi: 10.1208/s12249-024-02844-4.
2
Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.五阶段方法通过热熔挤出法对依曲韦林无定形固体分散体进行系统筛选和开发。
Mol Pharm. 2020 Feb 3;17(2):554-568. doi: 10.1021/acs.molpharmaceut.9b00996. Epub 2020 Jan 23.
3
Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.选择合适的聚合物用于超临界流体辅助制备卡维地洛固体分散体。
Int J Pharm. 2019 Jan 10;554:190-200. doi: 10.1016/j.ijpharm.2018.11.015. Epub 2018 Nov 8.
4
Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide.用于开发难溶性抗癌药物氟他胺无定形固体分散体的药物-聚合物混溶性、相互作用和沉淀抑制研究。
Drug Dev Ind Pharm. 2019 Aug;45(8):1277-1291. doi: 10.1080/03639045.2019.1606822. Epub 2019 May 21.
5
Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.中红外光谱法作为一种用于制备无定形固体分散体的聚合物选择工具。
J Pharm Pharmacol. 2014 Feb;66(2):244-55. doi: 10.1111/jphp.12079. Epub 2013 May 16.
6
Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.通过聚合物无定形固体分散体增强利伐沙班的生物制药性能。
Mol Pharm. 2018 Feb 5;15(2):652-668. doi: 10.1021/acs.molpharmaceut.7b01027. Epub 2018 Jan 16.
7
Drug-Carrier Miscibility in Solid Dispersions of Glibenclamide and a Novel Approach to Enhance Its Solubility Using an Effervescent Agent.格列本脲固体分散体中药物载体的混溶性及采用泡腾剂提高其溶解度的新方法。
AAPS PharmSciTech. 2022 Oct 17;23(8):284. doi: 10.1208/s12249-022-02437-z.
8
Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.利用 Flory-Huggins 相图作为制备无定形固体分散体的预配方工具:热熔挤出法和喷雾干燥法的比较。
J Pharm Pharmacol. 2014 Feb;66(2):256-74. doi: 10.1111/jphp.12141. Epub 2013 Nov 5.
9
Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.酮康唑二元和三元无定形固体分散体的分子间相互作用和相行为研究。
Mol Pharm. 2020 Mar 2;17(3):787-801. doi: 10.1021/acs.molpharmaceut.9b00970. Epub 2020 Feb 20.
10
Solid state interaction of raloxifene HCl with different hydrophilic carriers during co-grinding and its effect on dissolution rate.盐酸雷洛昔芬与不同亲水性载体在共研磨过程中的固态相互作用及其对溶出速率的影响。
Drug Dev Ind Pharm. 2009 Apr;35(4):455-70. doi: 10.1080/03639040802438365.

引用本文的文献

1
Mucin Mimics and Impacts the Function of Polymeric Inhibitors in Stabilizing Drug Supersaturation.粘蛋白模拟物并影响聚合物抑制剂在稳定药物过饱和状态中的功能。
Mol Pharm. 2025 Mar 3;22(3):1396-1407. doi: 10.1021/acs.molpharmaceut.4c01102. Epub 2025 Feb 20.
2
Mechanistic Insights into Amorphous Solid Dispersions: Bridging Theory and Practice in Drug Delivery.非晶态固体分散体的作用机制见解:药物递送中理论与实践的桥梁
Pharm Res. 2025 Jan;42(1):1-23. doi: 10.1007/s11095-024-03808-w. Epub 2025 Jan 23.

本文引用的文献

1
Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions.用热熔挤出法与各种节省材料的技术相结合制备三氯苯达唑无定形固体分散体。
Int J Pharm. 2023 Jun 10;640:122989. doi: 10.1016/j.ijpharm.2023.122989. Epub 2023 Apr 28.
2
Combining drug salt formation with amorphous solid dispersions - a double edged sword.将药物盐形成与无定形固体分散体相结合——一把双刃剑。
J Control Release. 2022 Dec;352:47-60. doi: 10.1016/j.jconrel.2022.09.056. Epub 2022 Oct 15.
3
3D printed oral solid dosage form: Modified release and improved solubility.
3D 打印口腔固体制剂:改善释放度和提高溶解度。
J Control Release. 2022 Nov;351:407-431. doi: 10.1016/j.jconrel.2022.09.023. Epub 2022 Sep 27.
4
Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance.无定形固体分散体:聚合物的作用及其在物理稳定性和体外性能方面的重要性。
Pharmaceutics. 2022 Aug 22;14(8):1747. doi: 10.3390/pharmaceutics14081747.
5
A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.基于热熔挤出的无定形固体分散体的系统和稳健评估:从理论预测到实际应用。
Int J Pharm. 2022 Aug 25;624:121951. doi: 10.1016/j.ijpharm.2022.121951. Epub 2022 Jun 23.
6
A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development.用于无定形固体分散体剂型开发的热熔挤出风险评估分类系统
Pharmaceutics. 2022 May 12;14(5):1044. doi: 10.3390/pharmaceutics14051044.
7
Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.纳米材料药物传递的最新进展与心血管疾病治疗的提升。
Int J Mol Sci. 2022 Jan 26;23(3):1404. doi: 10.3390/ijms23031404.
8
Influence of Plasdone S630 Ultra-an Improved Copovidone on the Processability and Oxidative Degradation of Quetiapine Fumarate Amorphous Solid Dispersions Prepared via Hot-Melt Extrusion Technique.聚维酮 S630Ultra-一种改良共聚维酮对富马酸喹硫平无定形固体分散体热熔挤出工艺及氧化降解的影响。
AAPS PharmSciTech. 2021 Jun 28;22(5):196. doi: 10.1208/s12249-021-02069-9.
9
Formulation and evaluation of raloxifene hydrochloride dry emulsion tablet using solid carrier adsorption technique.盐酸雷洛昔芬干混悬剂的处方前研究及固体载体吸附技术的应用。
Ther Deliv. 2021 Jul;12(7):539-552. doi: 10.4155/tde-2021-0025. Epub 2021 Jun 24.
10
Preformulation and characterization of raloxifene-loaded lipid nanoparticles for transdermal administration.载有雷洛昔芬的脂质纳米粒经皮给药的制剂前研究与评价。
Drug Deliv Transl Res. 2022 Mar;12(3):526-537. doi: 10.1007/s13346-021-00949-y. Epub 2021 Mar 7.